US2012052479A1PendingUtilityA1
Methods, compositions and devices for inducing stasis in tissues and organs
Individually held — no corporate assignee on recordPriority: Oct 22, 2003Filed: Jun 21, 2011Published: Mar 1, 2012
Est. expiryOct 22, 2023(expired)· nominal 20-yr term from priority
Inventors:Mark B. Roth
A01N 1/125A01N 1/10C12N 2500/02C12N 5/00
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention concerns the use of oxygen antagonists for inducing stasis in tissue, including all or part of organs. It includes methods and apparatuses for achieving stasis in tissue, so as to preserve and/or protect them. In specific embodiments, preservation methods and apparatuses for preserving tissue for transplantation purposes is provided.
Claims
exact text as granted — not AI-modified1 - 130 . (canceled)
131 . A method for inducing growth in integumentary tissue comprising:
a) isolating integumentary tissue; and b) exposing the tissue to an oxygen antagonist, wherein the oxygen antagonist is carbon monoxide; thereby inducing growth in integumentary tissue.
132 . The method of claim 131 , wherein the effective amount is a sublethal dose of the oxygen antagonist.
133 . The method of claim 131 , wherein the oxygen antagonist is a gas, semi-solid liquid, or liquid.
134 . The method of claim 133 , wherein the oxygen antagonist is a gas.
135 . The method of claim 131 , further comprising subjecting the tissue to a controlled temperature environment.
136 . The method of claim 135 , further comprising modulating environmental oxygen levels or removing the tissue from an environment having oxygen.
137 . The method of claim 131 , further comprising assessing the level of the oxygen antagonist and/or oxidative phosphorylation in the tissue.
138 . The method of claim 131 , further comprising removing the oxygen antagonist.
139 . The method of claim 131 , further comprising placing the tissue under a vacuum.
140 . The method of claim 131 , wherein the tissue is damaged.Join the waitlist — get patent alerts
Track US2012052479A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.